Your browser doesn't support javascript.
loading
Author Correction: Generation of a lethal mouse model expressing human ACE2 and TMPRSS2 for SARS-CoV-2 infection and pathogenesis.
Jeong, Gi Uk; Hwang, Insu; Lee, Wooseong; Choi, Ji Hyun; Yoon, Gun Young; Kim, Hae Soo; Yang, Jeong-Sun; Kim, Kyung-Chang; Lee, Joo-Yeon; Kim, Seong-Jun; Kwon, Young-Chan; Kim, Kyun-Do.
Affiliation
  • Jeong GU; Center for Infectious Disease Vaccine and Diagnosis Innovation (CEVI), Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea.
  • Hwang I; Division of Infectious Diseases, Department of Pediatrics, Boston Children's Hospital, Boston, MA, USA.
  • Lee W; Department of Pediatrics, Harvard Medical School, Boston, MA, USA.
  • Choi JH; Center for Infectious Disease Vaccine and Diagnosis Innovation (CEVI), Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea.
  • Yoon GY; Division of Vaccine Development Coordination, Center for Vaccine Research, National Institute of Infectious Diseases, National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea.
  • Kim HS; Center for Infectious Disease Vaccine and Diagnosis Innovation (CEVI), Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea.
  • Yang JS; Center for Infectious Disease Vaccine and Diagnosis Innovation (CEVI), Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea.
  • Kim KC; Center for Infectious Disease Vaccine and Diagnosis Innovation (CEVI), Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea.
  • Lee JY; Center for Infectious Disease Vaccine and Diagnosis Innovation (CEVI), Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea.
  • Kim SJ; Center for Emerging Virus Research, National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea.
  • Kwon YC; Center for Emerging Virus Research, National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea.
  • Kim KD; Center for Emerging Virus Research, National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea.
Exp Mol Med ; 2024 Sep 04.
Article in En | MEDLINE | ID: mdl-39227694

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Exp Mol Med Journal subject: BIOLOGIA MOLECULAR / BIOQUIMICA Year: 2024 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Exp Mol Med Journal subject: BIOLOGIA MOLECULAR / BIOQUIMICA Year: 2024 Document type: Article Country of publication: